Effect of dominant negative transforming growth factor-β receptor type II on cytotoxic activity of RAW 264.7, a murine macrophage cell line

被引:20
|
作者
Lee, Geun Taek
Hong, Jun Hyuk
Kwak, Cheol
Woo, Jaesung
Liu, Victoria
Lee, Chung
Kim, Isaac Yi
机构
[1] Univ Med & Dent New Jersey, Canc Inst New Jersey, Div Urol Oncol, New Brunswick, NJ USA
[2] Univ Ulsan, Coll Med, Dept Urol, Seoul, South Korea
[3] Univ Calif Irvine, Dept Urol, Orange, CA 92668 USA
[4] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA
关键词
D O I
10.1158/0008-5472.CAN-06-4263
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Transforming growth factor-beta (TGF-beta) is a potent suppressor of the immune system. In the present study, we investigated the effect of TGF-beta resistance on a murine macrophage cell line. RAW 264.7, by overexpressing a dominant negative TGF-beta receptor type II (T beta RIIDN) construct. As expected, T beta IIDN-expressing RAW cells, designated as RAW-T beta RIIDN, were resistant to TGF-beta signaling. When these cells were cocultured with the murine renal cell carcinoma cell line, Renca, a dramatic increase in apoptosis of Renca cells was observed. Simultaneously, elevated levels of inducible nitric oxide synthase (iNOS) and tumor necrosis factor-alpha, (TNF-alpha) in association with IFN-gamma were detected in RAW-T beta RIIDN cells. When the effects of TNF-alpha and iNOS were neutralized through the use of neutralizing antibody and N-G-methyl-L-arginine, respectively, the enhanced cytotoxicity of T beta RIIDN-RAW cells was partially reversed. Taken together, these results show that TGF-beta-resistant RAW 264.7 murine macrophage cells have increased cytotoxic activity that is in part mediated by iNOS and TNF-alpha.
引用
收藏
页码:6717 / 6724
页数:8
相关论文
共 50 条
  • [21] Effect of the B Subunit of the Cholera Toxin on the Raw 264.7 Murine Macrophage-Like Cell Line
    E. V. Navolotskaya
    V. B. Sadovnikov
    D. V. Zinchenko
    V. I. Vladimirov
    Y. A. Zolotarev
    V. M. Lipkin
    A. N. Murashev
    Russian Journal of Bioorganic Chemistry, 2019, 45 : 122 - 128
  • [22] Reduction in transforming growth factor-β type II receptor in mouse lung carcinogenesis
    Jakowlew, SB
    Moody, TW
    You, L
    Mariano, JM
    MOLECULAR CARCINOGENESIS, 1998, 22 (01) : 46 - 56
  • [23] Control of type II transforming growth factor-β receptor expression by integrin ligation
    Wang, DH
    Sun, LZ
    Zborowska, E
    Willson, JKV
    Gong, JG
    Verraraghavan, J
    Brattain, MG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (18) : 12840 - 12847
  • [24] Deleting Transforming Growth Factor-β type II receptor increases renal fibrosis
    Gewin, L. S.
    Zent, R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 480 - 480
  • [25] Arginase activity in a murine macrophage cell line (RAW264.7) stimulated with lipopolysaccharide from Actinobacillus actinomycetemcomitans
    Sosroseno, W
    Musa, M
    Ravichandran, M
    Ibrahim, MF
    Bird, PS
    Seymour, GJ
    ORAL MICROBIOLOGY AND IMMUNOLOGY, 2006, 21 (03): : 145 - 150
  • [26] Two neolignans from Perilla frutescens and their inhibition of nitric oxide synthase and tumor necrosis factor-α expression in murine macrophage cell line RAW 264.7
    Ryu, JH
    Son, HJ
    Lee, SH
    Sohn, DH
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (04) : 649 - 651
  • [27] Bisphenol a diglycidyl ether (BADGE) suppresses tumor necrosis factor-α production as a PPARγ agonist in the murine macrophage-like cell line, raw 264.7
    Nakamuta, M
    Enjoji, M
    Uchimura, K
    Ohta, S
    Sugimoto, R
    Kotoh, K
    Kato, M
    Irie, T
    Muta, T
    Nawata, H
    CELL BIOLOGY INTERNATIONAL, 2002, 26 (03) : 235 - 241
  • [28] Restoration of transforming growth factor-β type II receptor reduces tumorigenicity in the human adrenocortical carcinoma SW-13 cell line
    Yamamoto, N
    Imai, J
    Watanabe, M
    Hiroi, N
    Sugano, S
    Yoshino, G
    HORMONE AND METABOLIC RESEARCH, 2006, 38 (03) : 159 - 166
  • [29] Selective Deletion of the Natural Killer Cell Type II Transforming Growth Factor-β (TGF-β) Receptor Impairs Murine Lung Development and Function
    Gainer, D.
    Coyle, K. M.
    Vivier, E.
    Domnik, N.
    Ormiston, M. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [30] Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor β receptor type II
    Song, K
    Cornelius, SC
    Danielpour, D
    CANCER RESEARCH, 2003, 63 (15) : 4358 - 4367